Stevens-Johnson Syndrome in a Boy With Macrolide-Resistant Mycoplasma pneumoniae Pneumonia

被引:17
作者
Atkinson, T. Prescott [1 ]
Boppana, Suresh [1 ]
Theos, Amy [2 ]
Clements, L. Scott [4 ]
Xiao, Li [3 ]
Waites, Ken [3 ]
机构
[1] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[4] Univ S Alabama, Dept Pediat, Mobile, AL 36688 USA
关键词
Mycoplasma pneumoniae; Stevens-Johnson syndrome; drug resistance; pneumonia; REAL-TIME PCR; ERYTHEMA MULTIFORME; MUCOCUTANEOUS REACTIONS; INFECTION; CHILDREN; CHINA; HYPOGAMMAGLOBULINEMIA; SUSCEPTIBILITY; EPIDEMIOLOGY; PATHOGENESIS;
D O I
10.1542/peds.2010-2624
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Mycoplasma pneumoniae is a highly specialized parasitic bacterium that is a significant cause of community-acquired pneumonia in children. Although most such respiratory infections are mild, a minor percentage of patients require hospitalization and, occasionally, intensive treatment for respiratory failure. A variety of extrapulmonary sequelae of M pneumoniae infections have been described, including Stevens-Johnson syndrome. Macrolide resistance in M pneumoniae has developed rapidly in Asia, particularly in China, over the past decade and is now appearing in the United States. Emerging resistance to macrolides creates a therapeutic conundrum, particularly for pediatricians caring for young children in whom absolute or relative contraindications exist for the use of tetracyclines or fluoroquinolones, the 2 other main classes of drugs shown to be efficacious for M pneumoniae. We describe here the case of a child with a prolonged febrile illness associated with Stevens-Johnson-like mucocutaneous involvement who was found to have a respiratory infection with macrolide-resistant M pneumoniae. Pediatrics 2011; 127:e1605-e1609
引用
收藏
页码:E1605 / E1609
页数:5
相关论文
共 45 条
[1]   Deficient immune response to Mycoplasma pneumoniae in childhood asthma [J].
Atkinson, T. Prescott ;
Duffy, Lynn B. ;
Pendley, Donna ;
Dai, Yuling ;
Cassell, Gail H. .
ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (02) :158-165
[2]   Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections [J].
Atkinson, Thomas Prescott ;
Balish, Mitchell F. ;
Waites, Ken B. .
FEMS MICROBIOLOGY REVIEWS, 2008, 32 (06) :956-973
[3]  
BIBERFELD G, 1969, Scandinavian Journal of Infectious Diseases, V1, P39, DOI 10.3109/inf.1969.1.issue-1.06
[4]  
BIBERFELD G, 1968, J IMMUNOL, V100, P338
[5]   Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice [J].
Chu, HW ;
Campbell, JA ;
Rino, JG ;
Harbeck, RJ ;
Martin, RJ .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (06) :1119-1127
[6]   Corticosterolds and complicated Mycoplasma pneumoniae infection [J].
Cimolai, Nevio .
PEDIATRIC PULMONOLOGY, 2006, 41 (10) :1008-1009
[7]   Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany [J].
Dumke, R. ;
von Baum, H. ;
Lueck, P. C. ;
Jacobs, E. .
CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (06) :613-616
[8]   Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach [J].
Dumke, Roger ;
Schurwanz, Nicol ;
Lenz, Matthias ;
Schuppler, Markus ;
Lueck, Christian ;
Jacobs, Enno .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (08) :2726-2730
[9]  
FOY HM, 1983, YALE J BIOL MED, V56, P469
[10]   INFECTIONS CAUSED BY MYCOPLASMA-PNEUMONIAE AND POSSIBLE CARRIER STATE IN DIFFERENT POPULATIONS OF PATIENTS [J].
FOY, HM .
CLINICAL INFECTIOUS DISEASES, 1993, 17 :S37-S46